- Per vial formula: AOD 9604 5 mg · FRAG 176-191 5 mg · Adipotide 1 mg.
- Synergistic action: AOD & FRAG accelerate lipolysis; Adipotide selectively reduces fat cell vascularisation.
- Reconstitution: add 2 ml bacteriostatic water → 5.5 mg/ml. Swirl gently; refrigerate 2–8 °C.
- Sample research dosing: 0.25 ml (≈ 1.4 mg) to 0.5 ml (≈ 2.8 mg) sub-Q daily for 4–6 weeks.
-
Pharma-grade QC: ≥ 99 % purity, endotoxin < 0.03 EU/mg; scratch-code authenticity on every box.
⚗️ Storage & Handling
-
Store in a cool, dry place away from sunlight
-
Refrigeration recommended for stability
-
For research use only — not approved for human consumption outside supervised protocols
Parameter Standard Range Notes Dose 11–22 mg per injection Adjusted based on study design Frequency 2–3 times per week Ensures consistent compound availability Cycle Length 6–8 weeks Often followed by equal off‑cycle period Administration Subcutaneous or intramuscular injection Premixed vials allow precise delivery Timing Morning or pre‑training Aligns with natural metabolic activity windows
-
